Hyperacute extensive spinal cord infarction and negative spine magnetic resonance imaging: a case report and review of the literature

Rationale: Spinal cord infarction (SCI) accounted for only 1% to 2% of all ischemic strokes and 5% to 8% of acute myelopathies. Magnetic resonance imaging (MRI) play a role in the exclusion of non-ischemic etiology, but the diagnostic accuracy of this procedure may be low in confirming the diagnosis, even when the vast marrow lesions are present. Indeed, changes in MRI T2 can develop from hours to days, thus accounting for the low sensitivity in the setting of hyperacute (ie, within 6 hours of onset of symptoms).

For this reason, SCI remains a clinical diagnosis. Although the diagnostic work-up wide, up to 20% to 40% of cases of SCI are classified as cryptogenic. Here, we describe a case of cryptogenic longitudinally extensive transverse myelopathy due to SCI, with negative MRI and diffusion-weighted imaging at 9 hours after the initial symptoms.

patient concerns: A 51 years old woman presented to our emergency department with severe acute abdominal pain, nausea, vomiting, sudden-onset bilateral leg weakness with diffuse sensory loss and paraesthesia in the trunk and legs.
Diagnosis: On neurological examination, she showed severe paraparesis and sensory level D6. A spinal cord 3T MRI with gadolinium performed at 9 hours after onset of symptoms does not detect changes in the spinal cord. Due to the persistence of a suggestive clinical picture of myelopathy acute, 3T MRI of the spine was repeated after 72 hours showed hyperintense “pencil-like” signals mainly involving the gray matter of T1 to T6 at T2 sequence, slightly hypointense on T1 and the diffusion limited.

Intervention: Patients were given a salicylic acid (100 mg / d), a low molecular weight heparin prophylaxis, and start neuromotor rehabilitation.
Results: Two months later, a follow-up neurological examination revealed severe spastic paraparesis, there is a clear sensory level and sphincter control was poor with bladder distension.

Lesson: Apart from a relatively low frequency in the general population, SCI should be suspected in any patient presenting with symptoms of acute and progressive myelopathic, even without the presence of vascular risk factors. Thus, the clinical presentation consistent with a potential vascular syndromes involving the spinal cord MRI override initially negative and should not delay the timely and proper management.

Cultivated tomato (Solanum lycopersicum L.) suffer severe bottlenecks during domestication of the strain: Implications of the chloroplast genome

In a variety of plants, genetic bottlenecks occur through domestication can limit plant resistance to biotic and abiotic stresses. In this study, we investigated the nucleotide diversity in tomato chloroplast genome by sequencing seven plastomes of cultivated accessions from the Campania region (southern Italy) and two wild species among the closest (Solanum pimpinellifolium) and most distantly related (S. neorickii) tomato species cultivated. comparative analysis between the chloroplast genome sequenced in this work and are available at GenBank allowed to evaluate the variability plastomes and defining phylogenetic relationships.

A dramatic reduction in genetic diversity detected in cultivated tomatoes, however, de novo mutations some, still distinguishable tomatoes cultivated from the nearest wild relative S. pimpinellifolium, which are detected and can potentially be used as a diagnostic marker. phylogenetic analysis confirms that S. pimpinellifolium is the closest ancestor of all cultivated tomatoes. Local accession all gathered together and strictly related to other cultivated tomato (S. lycopersicum group). Noteworthy, S. lycopersicum var. cerasiforme resulting in a mix of both cultivated and wild tomato genotypes for one of the two accessions analyzed teem with tomatoes cultivated, whereas others with S. pimpinellifolium.

 Hyperacute extensive spinal cord infarction and negative spine magnetic resonance imaging: a case report and review of the literature
Hyperacute extensive spinal cord infarction and negative spine magnetic resonance imaging: a case report and review of the literature

The whole exome Analysis of Congenital Muscular Dystrophy and congenital myopathy patients from India Unveils Wide Spectrum of Known and Novel Mutation

Background: Congenital muscular dystrophy (CMD) and the congenital myopathies (CM) is a clinically heterogeneous group of genetic and degenerative primary muscle disorder with onset at birth or during infancy. Due to the extensive heterogeneity, clinical examination and analysis of protein-based often fail to identify the genetic causes of this disease.

Methods: Whole exome sequencing (WES) conducted to identify genetic mutations and diagnose pathogens cohort of 36 hard-to-diagnose cases CM CMD and Indian origin, using a variant of the call and a rigorous filtration process variants. Furthermore, in silico modeling and molecular dynamics (MD) study conducted for a number of novels and missense variants.

Results: A total of 33 and 21 rare and damaging mutations identified in 28 genes were previously reported in CMD and CM based OMIM, ClinVar and Orphanet, respectively. We can accurately diagnose 54% of patients (n = 12/22) in the group of CMD and 35% of patients (n = 5/14) in the group CM. Furthermore, the study for the MD is located in LMNA mutations, lama2 and RYR1, indicating that the wild type of protein is more stable than their mutant counterparts, implying a potential mechanism of pathogenesis.

NATtrol Zika Virus (PRVABC59), External Run Control, Low (6 x 1.0 mL)

NATZIKV(PRV)-ERCL 6 x 1.0 mL
EUR 350

NATtrol Staphylococcus aureus (MSSA); -mecA, External Run Control, Low (6X1mL)

NATSAU(MSSA)-ERCL 6X1mL
EUR 360

NATtrol HIV Type 1 Strain: IIIB External Run Control, Low (6 X 1 mL)

NATHIV1-ERCL 6 X 1 mL
EUR 360

NATtrol Mycoplasma pneumoniae M129, External Run Control, Low (6 X 1 mL)

NATMPN(M129)-ERCL 6 X 1 mL
EUR 360

NATtrol Neisseria gonorrhoeae Z017, External Run Control, Low (6 X 1 mL)

NATNG-ERCL 6 X 1 mL
EUR 360

NATtrol Staphylococcus aureus (MRSA) External Run Control, Low (6 X 1 mL)

NATSAU(MRSA)-ERCL 6 X 1 mL
EUR 360

NATtrol Clostridium difficile NAP1, External Run Control, Low (6 X 1 mL)

NATCDI(NAP1)-ERCL 6 X 1 mL
EUR 438

NATtrol Cytomegalovirus (CMV) Strain: AD-169 External Run Control, Low (6X1 mL)

NATCMV-ERCL 6X1 mL
EUR 360

NATtrol Escherichia coli 0157:H7;EDL933, External Run Control, Low (6 X 1 mL)

NATECO(933)-ERCL 6 X 1 mL
EUR 360

NATtrol Chlamydia trachomatis LGV II 434, External Run Control, Low (6 X 1 mL)

NATCT(434)-ERCL 6 X 1 mL
EUR 360

NATtrol BK Virus External Run Control, Medium (6 X 1 mL)

NATBK-ERCM 6 X 1 mL
EUR 438

NATtrol Chlamydia trachomatis serotype D, External Run Control, Low (6 X 1 mL)

NATCT(D-UW3)-ERCL 6 X 1 mL
EUR 360

NATtrol Mycoplasma genitalium External Run Control (6 x 0.25mL)

NATMGN-ERC 6 x 0.25mL
EUR 301

NATtrol Zika Virus, External Run Control, Medium (6 x 1 mL)

NATZIKV-ERCM 6 x 1 mL
EUR 425

NATtrol P. jirovecii Recombinant External Run Control (6 x 0.5mL)

NATPJI-ERC 6 x 0.5mL
EUR 365

NATtrol Flu/RSV/SARS-CoV-2 External Run Control (6 x 0.5mL)

NATFRC-ERC -
EUR 278

NATtrol Epstein Barr Virus (EBV) Strain: B95-8, External Run Control-Low (6X1mL)

NATEBV-ERCL 6X1mL
EUR 349

NATtrol Zika Virus (PRVABC59), External Run Control, Medium (6 x 1.0mL)

NATZIKV(PRV)-ERCM 6 x 1.0mL
EUR 425

NATtrol Chlamydia trachomatis LGV II 434, External Run Control, Medium (6X1mL)

NATCT(434)-ERCM 6X1mL
EUR 438

NATtrol Staphylococcus aureus (MSSA); -mecA,External Run Control, Medium (6X1mL)

NATSAU(MSSA)-ERCM 6X1mL
EUR 438

NATtrol Cytomegalovirus (CMV) Strain:AD-169 External Run Control, Medium (6X1mL)

NATCMV-ERCM 6X1mL
EUR 438

NATtrol Chlamydia trachomatis serotype D, External Run Control, Medium (6X1mL)

NATCT(D-UW3)-ERCM 6X1mL
EUR 438

NATtrol HIV Type 1 Strain: IIIB External Run Control, Medium (6 X 1 mL)

NATHIV1-ERCM 6 X 1 mL
EUR 438

NATtrol Mycoplasma pneumoniae M129, External Run Control, Medium (6 X 1 mL)

NATMPN(M129)-ERCM 6 X 1 mL
EUR 438

NATtrol Neisseria gonorrhoeae Z017, External Run Control, Medium (6 X 1 mL)

NATNG-ERCM 6 X 1 mL
EUR 438

NATtrol Staphylococcus aureus (MRSA) External Run Control, Medium (6 X 1 mL)

NATSAU(MRSA)-ERCM 6 X 1 mL
EUR 438

NATtrol Clostridium difficile NAP1, External Run Control, Medium (6 X 1 mL)

NATCDI(NAP1)-ERCM 6 X 1 mL
EUR 557

NATtrol Epstein Barr Virus (EBV) Strain:B95-8,External Run Control-Medium(6X1mL)

NATEBV-ERCM 6X1mL
EUR 425

NATtrol Escherichia coli 0157:H7;EDL933, External Run Control, Medium (6 X 1 mL)

NATECO(933)-ERCM 6 X 1 mL
EUR 438

NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) External Run Control (6 x 0.5 mL)

NATSARS(COV2)-ERC 6 x 0.5 mL
EUR 416

NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) External Run Control (6 x 1.0 mL)

NATSARS(COV2)-ERC1 6 x 1.0 mL
EUR 568

NATtrol Influenza A/B Positive Control (6 x 0.5mL)

NATFLUAB-6C 6 x 0.5mL
EUR 211

NATtrol Influenza A/B Positive Control (6 X 0.5 mL)

NATFLUA/B-6MC 6 X 0.5 mL
EUR 227

NATtrol Influenza A/B  Positive Control (6 X 0.5 mL)

NATFLUAB-6C-IVD 6 X 0.5 mL
EUR 231

NATtrol Influenza A/B Positive Control (6 X 0.5 mL)

MDZ046 6 X 0.5 mL
EUR 272.16
Description: Please contact Gentaur in order to receive the datasheet of the product.

NATtrol Influenza Negative Control (6 X 0.5 mL)

NATCXVA9-6MC 6 X 0.5 mL
EUR 220

NATtrol Influenza/RSV Negative Control (6 x 0.5mL)

NATCXVA9-6C 6 x 0.5mL
EUR 220

NATtrol Influenza/RSV Positive Control (6 x 0.25mL)

NATFLURSV-6L 6 x 0.25mL
EUR 272

NATtrol Influenza/RSV Positive Control (6 x 0.5 mL)

NATFLURSV-6C 6 x 0.5 mL
EUR 221

NATtrol Influenza/RSV Negative Control (6 X 0.5 mL)

NATCXVA9-6C-IVD 6 X 0.5 mL
EUR 240

NATtrol Influenza/RSV Negative Control (6 X 0.5 mL)

MDZ045 6 X 0.5 mL
EUR 272.16
Description: Please contact Gentaur in order to receive the datasheet of the product.

Influenza Rapid Test Control Pack (3 X 1.5mL)

KZMC033 3 X 1.5mL
EUR 59

Influenza A virus HA Control/blocking peptide

AB-23091-P 100ug
EUR 196.8

NATtrol Influenza A H1N1 Positive Control (6 X 0.5 mL)

NATFLUAH1N1-6MC 6 X 0.5 mL
EUR 227

Purified Influenza A Neuraminidase (H1N1-NA) protein control for western blot

H1N1NA11-C 100 ul
EUR 343.2

Influenza A virus (H5N1) matrix protein 2 Control/blocking peptide

M2E15-P 100 ug
EUR 196.8

Influenza A virus (H1N1) matrix protein 2 Control/blocking peptide

M2E16-P 100 ug
EUR 196.8

Influenza A virus (H9N2) matrix protein 2 Control/blocking peptide

M2E17-P 100 ug
EUR 196.8

Human anti-H. Influenzae B (Hib-PRP) IgG negative control serum

980-101-HNC 1 ml
EUR 196.8

Human anti-H. Influenzae B (Hib-PRP) IgG positive control serum

980-101-HPC 1 ml
EUR 270

Recombinant Purified Hemagglutinin Influenza A Virus (H11N2; A/duck/Yangzhou/906/2002) protein control for Western

H11N2-01-C 100 ul
EUR 343.2

Influenza A virus (H5N1) matrix protein 2 hybrid sequence Control/blocking peptide

M2E11-P 100 ug
EUR 196.8

Goat IgG (-ve control for flow cytometry) (isotype control)

20011-100 100 test
EUR 123.6

Human anti-H. Influenzae B protein D (Hib-PDG) IgG negative control serum

980-200-01N 1 ml
EUR 196.8

Human anti-H. Influenzae B protein D (Hib-PDG) IgG positive control serum

980-200-02P 1 ml
EUR 270

Recombinant Purified Hemagglutinin Influenza A Virus H1N1 H1 (H1N1) (A/New Caledonia/20/99) protein control for Western

H1N1-01-C 100 ul
EUR 343.2

Core Panel Multi-Tumor control slides, set of 5

TS900 Set of 5
EUR 145
Description: Core Panel Multi-Tumor control slides, set of 5

Core Panel Multi-Tumor control slides, set of 25

TS900-25 Set of 25
EUR 425
Description: Core Panel Multi-Tumor control slides, set of 25

Low control Human Serum

35-S4321H000-L4 10 ml
EUR 139.2
Description: Low control human Serum

Breast Panel Multi-Tumor control slides, set of 5

TS901 Set of 5
EUR 145
Description: Breast Panel Multi-Tumor control slides, set of 5

Breast Panel Multi-Tumor control slides, set of 25

TS901-25 Set of 25
EUR 395
Description: Breast Panel Multi-Tumor control slides, set of 25

BSA Control for Age-BSA

2221-BSA each
EUR 210

BSA Control for AGE-BSA

35R-AA007 10 mg
EUR 268.8
Description: BSA Control for AGE protein (BSA modified), Cat No. 30R-AA007

Deer IgG, semi-pure for ELISA (Control, non-immune, isotype control)

20024-2 100 ug
EUR 270

Control for ER, 4 cases (1.5mm)

ERC081 1
EUR 102
Description: IHC control array containing 4 breast cancer cases of strong, moderate, weak/nil estrogen receptor (ER) expressers in duplicates

Control for PR, 3 cases (1.5mm)

PRC061 1
EUR 102
Description: IHC control array containing 3 breast cancer cases of strong, moderate, low/negative progesterone receptor (PR) expressers in duplicates

Flow Control Fitting for Flypad

FLY1254 EACH
EUR 101.84

Flow Control Fitting for Blowgun

FLY1252 EACH
EUR 80.95

Control for DOG1, 3 cases (1.5mm)

DOG1061 1
EUR 102
Description: IHC control array containing 3 GIST cases of strong, moderate, weak/nil DOG1 expressers in duplicates

Control for HER2, 4 cases (1.5mm)

HRC081 1
EUR 102
Description: IHC control array containing 4 breast cancer cases of strong, moderate, low and negative HER2 breast cancer expressers in duplicates

Recombinant Purified Hemagglutinin Influenza A Virus H5N1 H5 (H5N1) (A/chicken/India/NIV33487/2006) (17-531aa) protein control for Western

H5N11-C 100 ul
EUR 343.2

Control for Ckit, 6 samples (1.5mm)

CKIT061 1
EUR 102
Description: Gastrointestinal stroma tumors, 6 cores, 3 cases in duplicates showing strong, moderate and no expression of cKit molecule.

Human Apolipoprotein B protein control for WB

APOB21-C 100 ul
EUR 343.2

Low Level Semivolatile Control Sample

CLPS-LC-ALCS 1ML
EUR 130.8

SLLK, Control Peptide for TSP1 Inhibitor

HY-P0301 1mg
EUR 159.6

Rat neurofascin (Nfasc)-control Control/blocking peptide

AB-23249-CP 100ug
EUR 196.8

RNA Extraction Control 670

BIO-38040 100 Reactions Ask for price

RNA Extraction Control 670

BIO-38041 500 Reactions Ask for price

RNA Extraction Control 560

BIO-38044 100 Reactions Ask for price

RNA Extraction Control 560

BIO-38045 500 Reactions Ask for price

RNA Extraction Control 610

BIO-38048 100 Reactions Ask for price

RNA Extraction Control 610

BIO-38049 500 Reactions Ask for price

Control/Blocking peptide for Human WNT5a

WNT511-P 100 ug
EUR 196.8

Rat IgG2a Isotype Control LOW ENDOTOXIN

12-168-C100 0.1 mg
EUR 163.2

Rat IgG2b Isotype Control LOW ENDOTOXIN

12-169-C100 0.1 mg
EUR 163.2

Rec. Human CD21 protein control for WB

CD21-C 100 ul
EUR 343.2

pMD18- Control

PVT10563 2 ug
EUR 319.2

pMD19- Control

PVT10564 2 ug
EUR 319.2

PAS/Glycogen, For Digestion (Control Slides)

TCS0024-100 100 Slides
EUR 847.2

PAS/Glycogen, For Digestion (Control Slides)

TCS0024-25 25 Slides
EUR 278.4

PAS/Glycogen, For Digestion (Control Slides)

TCS0024-5 5 Slides
EUR 117.6

Thiostatin Rat protein, control for western

TSTN11-C 100 ul
EUR 343.2

Mouse IgG (-ve control for flow cytometry)

20008-1-100 100 tests
EUR 123.6

Quality Control

abx098966-1vial 1 vial
EUR 360

Rabbit IgG (-ve control for flow cytometry)

20009-1-100 100 tests
EUR 123.6

Rat IgG-PE conjugate (isotype control) (Isotype control)

20005-PE 25 tests
EUR 242.4

Rat IgG-HRP conjugate (isotype control) (Isotype control)

20005-HP 100 ug
EUR 196.8

Rat IgG-FITC conjugate (isotype control) (Isotype control)

20005-F 100 ug
EUR 196.8

PIPET CONTROLLER CONTROL BOARD

357484 1/pk
EUR 104.4
Description: Falcon Liquid Handling Equipment; Falcon Pipet Controllers and Accessories

Control Sections for FD NeuroSilver™ Kit

PCS101 each
EUR 69.6

Purified, Human S100 protein control for WB

S1002-C 100 ul
EUR 343.2

Control/Blocking peptide for Human WNT-1

WNT111-P 100 ug
EUR 548.4

Rat IgG-Biotin conjugate (isotype control) (Isotype control)

20005-B 100 ug
EUR 196.8

SLLK, Control Peptide for TSP1 Inhibitor(TFA)

HY-P0301A 5mg
EUR 456

Purified, Bovine S100 protein control for WB

S1001-C 100 ul
EUR 343.2

Negative Control Antibody for Mouse Monoclonals

V8785-100UG 100ug
EUR 349.3
Description: To serve as a true negative control for various procedures, this monoclonal IgG should be used under the identical conditions and at the same dilution as the rabbit monoclonal antibody being used for a positive reaction.

Negative Control Antibody for Mouse Monoclonals

V8785-20UG 20ug
EUR 153.3
Description: To serve as a true negative control for various procedures, this monoclonal IgG should be used under the identical conditions and at the same dilution as the rabbit monoclonal antibody being used for a positive reaction.

Negative Control Antibody for Mouse Monoclonals

V8785SAF-100UG 100ug
EUR 349.3
Description: To serve as a true negative control for various procedures, this monoclonal IgG should be used under the identical conditions and at the same dilution as the rabbit monoclonal antibody being used for a positive reaction.

Control siRNA Vector (pGB-control)

9500C-20 each
EUR 405.6

Positive Control for Anti-Rat MEH Antibody

MEHCON 100 uL
EUR 150

Rat Control IgG

AC034 100 ul
EUR 159.6

Goat IgG control

31R-AG001 1 mg
EUR 152.4
Description: Goat Immunoglobulins Goat IgG control

Goat IgG Control

GT15900 1 mg
EUR 199.2

MG-BSA Control

STA-306 100 µg
EUR 386.4
Description:
  • Methylglyoxal-BSA (MG-BSA) may be used as a positive control. 100 µg at 1 mg/mL in PBS.
  • Provided at 1 mg/mL

Positive Control for Anti-Rat CYP2C Antibody

P2CCON 100 uL
EUR 150

Positive Control for Anti-Rat CYP2D Antibody

P2DCON 100 uL
EUR 150

Human Liver Cathepsin B protein control for Western blot

CTHB11-C 100 ul
EUR 343.2

Mouse IgG Control

10R-I169A 250 ug
EUR 152.4
Description: Mouse Immunoglobulins Mouse IgG Control

Mouse Control IgG

AC011 100 ul
EUR 159.6

Mouse IgM Control

ICIGMF-100 100 µg
EUR 239.4

Mouse IgM Control

ICIGMPU-100 100 µg
EUR 239.4

CEL-BSA Control

STA-302 100 µg
EUR 386.4
Description:
  • N-epsilon-(carboxyethyl) lysine (CEL) modified BSA may be used as a positive control. 100 µg at 1 mg/mL in PBS.
  • Provided at 1 mg/mL in 1X PBS

CML-BSA Control

STA-314 100 µg
EUR 386.4
Description:
  • CML-BSA may be used as a positive control. 100 µg.
  • Provided at 1 mg/mL in 1X PBS

MDA-BSA Control

STA-333 100 µg
EUR 386.4
Description:
  • MDA-BSA (Malondialdehyde-BSA) may be used as a positive control. 100 µg.
  • Provided at 1 mg/mL in 1X PBS

HNE-BSA Control

STA-335 100 µg
EUR 386.4
Description:
  • HNE-BSA (4-Hydroxynonenal-BSA) may be used as a positive control. 100 µg.
  • Provided at 1 mg/mL in 1X PBS

Positive Control for Anti-Rat CYP2B1 Antibody

P2B1PTCON 100 uL
EUR 150

Positive Control for Anti-Rat CYP3A2 Antibody

P3A2PTCON 100 uL
EUR 150

Haptoglobin Human Plasma protein control for WB

HGLB18-C 100 ul
EUR 343.2

Control/Blocking peptide for Mouse Vimentin (Vim)

VIM11-C 100 ug
EUR 196.8

EUROSTAR 200 control Overhead Stirrer with wireless control unit

STI2876 EACH
EUR 5433.6

EUROSTAR 100 control Overhead Stirrer with wireless control unit

STI2878 EACH
EUR 3648

Rabbit Control IgG

AC005 100 ul
EUR 159.6

Rabbit IgG Control

31R-AR001 500 ug
EUR 159.6
Description: Purified Normal Rabbit IgG

Human IgG1 Control

HY-P9900 5mg
EUR 776.4

Mouse IgG1 Control

ICIGG1A-50 50 µg
EUR 387.6

Mouse IgG1 Control

ICIGG1AC750-50 50 µg
EUR 855.6

Mouse IgG1 Control

ICIGG1CFB-100 100 µg
EUR 387.6

Mouse IgG1 Control

ICIGG1F-100 100 µg
EUR 239.4

Mouse IgG1 Control

ICIGG1PE-50 50 µg
EUR 387.6

Mouse IgG1 Control

ICIGG1PP-100 100 µg
EUR 387.6

Mouse IgG1 Control

ICIGG1PP5.5-100 100 µg
EUR 387.6

Mouse IgG1 Control

ICIGG1PU-100 100 µg
EUR 239.4

Mouse IgG3 Control

ICIGG3A-50 100 µg
EUR 777.6

Mouse IgG3 Control

ICIGG3CFB-100 100 µg
EUR 465.6

Mouse IgG3 Control

ICIGG3F-100 100 µg
EUR 387.6

Mouse IgG3 Control

ICIGG3PE-50 50 µg
EUR 621.6

Mouse IgG3 Control

ICIGG3PU-100 100 µg
EUR 387.6

VACUUM CONTROL KIT

ZAFSVCKIT EACH
EUR 381.24

Mouse IgG Isotype control (purified) validated for

NG903 7 ml
EUR 195
Description: Mouse IgG Isotype control (purified) validated for IHC; Ready-To-Use

Mouse IgG Isotype control (purified) validated for

NG903C 1 ml
EUR 275
Description: Mouse IgG Isotype control (purified) validated for IHC; Concentrate; Minimum 1:50 dilution

Mouse IgM Isotype control (purified) validated for

NG906 7 ml
EUR 265
Description: Mouse IgM Isotype control (purified) validated for IHC; Ready-To-Use

Mouse IgM Isotype control (purified) validated for

NG906C 1 ml
EUR 295
Description: Mouse IgM Isotype control (purified) validated for IHC; Concentrate

Positive Control for Anti-Human CYP3A Antibody

P3ACON 100 uL
EUR 150

EUROSTAR 60 control Overhead Stirrer with wireless control unit

STI2886 EACH
EUR 2894.4

Vacuum Controller w Control Unit

PUM3016 EACH
EUR 2559.6

Control/Blocking peptide for Ephrin-B2 antibody

NIVE2B-C 100 ug
EUR 196.8

Positive Control for Anti-Human CYP1B1 Antibody

PH1B1CON 100 uL
EUR 150

Positive Control for Anti-Human CYP2E1 Antibody

P2E1PTCON 100 uL
EUR 150

Positive Control for Anti-Human CYP1A2 Antibody

P1A2CON 100 uL
EUR 150

Chicken Egg Ovalbumin protein control for Western

OVA11-C 100 ul
EUR 343.2

PER.C6 Control Antigen

F536 70 ul
EUR 400.8
Description: PER.C6 Control Antigen by Cygnus Technologies is available in Europe via Gentaur.

CHO Control Antigen

F063 50 ul
EUR 262.8
Description: CHO Control Antigen by Cygnus Technologies is available in Europe via Gentaur.

SF9 Control Antigen

F127 50 ul
EUR 288
Description: SF9 Control Antigen by Cygnus Technologies is available in Europe via Gentaur.

Mouse IgG2a Control

ICIGG2AA-50 50 µg
EUR 387.6

Mouse IgG2a Control

ICIGG2AB-100 100 µg
EUR 239.4

Mouse IgG2a Control

ICIGG2ACFB-100 100 µg
EUR 387.6

Mouse IgG2a Control

ICIGG2AF-100 100 µg
EUR 239.4

Mouse IgG2a Control

ICIGG2APE-50 50 µg
EUR 387.6

Mouse IgG2a Control

ICIGG2APP-100 100 µg
EUR 387.6

Mouse IgG2a Control

ICIGG2APP5.5-100 100 µg
EUR 387.6

Mouse IgG2a Control

ICIGG2APU-100 100 µg
EUR 239.4

Mouse IgG2b Control

ICIGG2BA-50 50 µg
EUR 387.6

Mouse IgG2b Control

ICIGG2BCFB-100 100 µg
EUR 387.6

Mouse IgG2b Control

ICIGG2BF-100 100 µg
EUR 239.4

Mouse IgG2b Control

ICIGG2BPE-50 50 µg
EUR 387.6

Mouse IgG2b Control

ICIGG2BPP-100 100 µg
EUR 387.6

Mouse IgG2b Control

ICIGG2BPP5.5-100 100 µg
EUR 387.6

Mouse IgG2b Control

ICIGG2BPU-100 100 µg
EUR 239.4

Human Pancreatic Amylase protein control for Western blot

PAMY13-C 100 ul
EUR 343.2

DNA Extraction Control 670, (Red Cap)

BIO-35028 500 rxns Ask for price

DNA Extraction Control 670, (Red Cap)

BIO-35029 2000 rxns Ask for price

Rat Ceruloplasmin protein control for western blot

CP17-C 100 ul
EUR 343.2

Positive control tissue section for each individua

Control-slides- Set of 5
EUR 119
Description: Positive control tissue section for each individual antibody; Based on availability; INQUIRE

Conclusions: The findings WES has led us to identify new variants were reported as well as for the first time in India CMD and CM patients. This allows us to achieve an accurate genetic diagnosis that are otherwise difficult using conventional diagnostic tools. Transferring WES findings for clinical practice will help the clinical care of patients affected guided and informed genetic counseling.

Related Posts

Leave a Reply

Your email address will not be published.